GAIL (India) Limited has secured regulatory approval for its strategic equity investment in Leafiniti Bioenergy Private Limited, marking a significant milestone in the state-owned energy company's expansion into the bioenergy sector.

Regulatory Approval Details

The Department of Investment and Public Asset Management (DIPAM) has granted its concurrence for GAIL's equity participation proposal. The approval was formally communicated through the Ministry of Petroleum and Natural Gas (MOPNG) in a letter dated 04.02.2026, which referenced DIPAM's office memorandum issued on 22.01.2026.

Background and Timeline

This approval follows GAIL's earlier commitment to the investment, as evidenced by the execution of a Share Subscription cum Shareholders Agreement with Leafiniti Bioenergy Private Limited on 11.08.2025. The company had previously disclosed this agreement to the stock exchanges as part of its regulatory compliance obligations.

Strategic Significance

The investment represents GAIL's continued focus on diversifying its energy portfolio and expanding into renewable energy segments. Leafiniti Bioenergy operates in the bioenergy sector, aligning with GAIL's broader strategic objectives in clean energy initiatives.

Compliance and Disclosure

GAIL has made this disclosure in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company secretary, Mahesh Kumar Agarwal, signed the disclosure document on 05.02.2026, ensuring timely communication to both the National Stock Exchange of India Limited and BSE Limited.

The approval from DIPAM, which oversees strategic decisions for public sector enterprises, provides GAIL with the necessary regulatory clearance to proceed with its equity participation in Leafiniti Bioenergy Private Limited.

GAIL (India) Limited announced its Q3FY26 quarterly results showing continued pressure on profitability with net profit declining both on year-on-year and quarter-on-quarter basis. The company's results reflect challenging market conditions in the natural gas and petrochemicals sectors, with sequential quarterly performance also showing deterioration across key financial metrics including EBITDA performance.

Financial Performance Overview

The company's standalone financial results showed marked deterioration in profitability metrics across multiple timeframes. Net profit after tax fell to ₹1,602.57 crore, representing a substantial 59% decline from ₹3,867.38 crore reported in the same quarter last year. On a sequential basis, the decline was 28% from ₹2,220 crore in the previous quarter, indicating continued margin pressures.

EBITDA Performance Analysis

The company's operational efficiency showed significant deterioration during the quarter. EBITDA declined to ₹2,655 crore from ₹3,190 crore in the previous quarter, marking a 16.8% sequential decline. More concerning was the compression in EBITDA margin, which fell to 7.79% from 9.11% in the preceding quarter, indicating weakening operational profitability amid challenging market conditions.

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, GAIL demonstrated resilience in revenue generation while facing margin pressures. Revenue from operations increased marginally by 2.3% to ₹1,03,899.50 crore compared to ₹1,01,580.11 crore in the corresponding period last year.

Segment-Wise Performance

The company's diversified business portfolio showed mixed results across different segments. Natural gas transmission remained the strongest performer, while petrochemicals faced significant challenges.

Natural Gas Transmission emerged as the most profitable segment, generating ₹1,376.09 crore in segment results compared to ₹1,370.29 crore in the same quarter last year. Natural Gas Marketing contributed ₹30,605.41 crore in revenue for the quarter, though segment results declined to ₹853.18 crore from ₹2,880.98 crore in the previous year. Petrochemicals segment reported a loss of ₹482.64 crore in segment results, compared to a marginal profit of ₹4.68 crore in the corresponding quarter last year.

Board Meeting and Regulatory Compliance

The Board of Directors meeting was held on January 31, 2026, commencing at 2:00 p.m. and concluding at 5:15 p.m. The board approved the unaudited financial results for the quarter and nine months ended December 31, 2025, along with the payment of interim dividend. The results were filed with stock exchanges in compliance with SEBI regulations.

Dividend Declaration and Corporate Actions

The Board of Directors approved an interim dividend of ₹5.00 per equity share (face value ₹10 each), amounting to ₹3,287.55 crore. The record date for dividend payment has been fixed as February 5, 2026.

Regulatory Filing and Newspaper Publication

In compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, GAIL has published its unaudited financial results for the quarter and nine months ended December 31, 2025 in newspapers. The company filed the necessary documents with National Stock Exchange of India Limited (Scrip Code: GAIL-EQ) and BSE Limited (Scrip Code: 532155) on February 2, 2026.

Key Financial Ratios and Regulatory Matters

The company's financial health indicators showed mixed trends with debt equity ratio at 0.25 times compared to 0.23 times in the previous year, while current ratio declined to 0.99 times from 1.22 times. Operating margin compressed to 4.71% from 5.75%, and net profit margin fell significantly to 4.71% from 11.09%.

The company continues to face regulatory challenges, including appeals against provisional tariff orders and a Central Excise demand of ₹2,889 crore related to Naphtha classification before the Supreme Court.